Public Sector Pension Investment Board Atara Biotherapeutics, Inc. Transaction History

Public Sector Pension Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $1.7 Million - $3.39 Million	-201,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $1.69 Million - $2.29 Million	115,000 Added 133.72%	201,000 $3.17 Million
Q3 2021 Nov 12, 2021	BUY	$11.99 - $17.9 $1.03 Million - $1.54 Million	86,000 New	86,000 $1.54 Million
Q1 2020 May 14, 2020	SELL	$5.69 - $17.78 $907,407 - $2.84 Million	-159,474 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $1.74 Million - $2.68 Million	159,474 New	159,474 $2.63 Million

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.